Maciej Chrystowski

Maciej Chrystowski is a Director at Bridgepoint and a member of the Technology team. He currently sits on the board of Infinigate. He has been involved in acquisitions including Kyriba, Infinigate, Vivacy, Pharmazell, and Infront. Before joining Bridgepoint in 2011, he worked in the investment banking division of Bank of America Merrill Lynch in London. He graduated from ESCP-EAP and City University and holds a Diplom-Kaufmann degree

Maciej Chrystowski’s appointment as a member of the Esker Supervisory Board became effective on Friday 24 January 2025 for the remainder of Steve Vandenberg’s term of office, i.e. until the 2028 general meeting of shareholders called to approve the financial statements for the 2027 fiscal year.